Matt McGuire
Dr. Wilson
25 November 2014
Chronic Bronchitis Chronic obstructive pulmonary disease (COPD) affects an estimated 24 million individuals in the United States, where half of these people do not even know they have it (COPD Foundation 2014). COPD governs a deluge of ailments including: emphysema, refractory asthma, some forms of bronchiectasis, and the very prevalent chronic bronchitis. Chronic Bronchitis is a long-term pulmonary disease where there is a problem in the airway of the lungs, making it very difficult to breath, especially when one is trying to exhale air out of the airways. It is clinically defined as cough production of sputum occurring on most days in three consecutive months over two consecutive years (Chaudhry
…show more content…
Chronic Bronchitis has some fairly common disease symptoms (cough, increased mucus production, shortness of breath/difficulty breathing, fatigue, and wheezing) making it tricky to spot for the diseased individual (Chaudhry et al., 2013). Though it can be easy to diagnose with a doctor/physician present. Spirometry is a simple, non-invasive technique used to diagnose individuals with possible COPD. The most commonly examined values in spirometry tests are FEV1 (forced expiratory volume in one second) and FVC (forced vital capacity). The two values are calculated into a ratio, consequently named the FEV1/FVC ratio. If this ratio drops below 70-75%, (depending on the guideline) the individual would be diagnosed with a type of COPD, and likely chronic bronchitis. Once an individual is diagnosed with chronic bronchitis, they have a few options for treatment. Although chronic bronchitis cannot be cured, there are several effective methods to reduce the effect of the disease. For the chronic smokers that are diagnosed, smoking cessation is the single most effective intervention in chronic bronchitis (Chaudhry et al., 2013). Bronchodilators (beta-2 agonists) can be inhaled to cause bronchodilation of the smooth muscles cells, and corticosteroids act by inhibiting transcriptions factors to reduce inflammation of the airway (Chaudhry et al., 2013). Although both corticosteroids and bronchodilators improve FEV1, reduce
R.W. appears with progressive difficulty getting his breath while doing simple tasks, and also having difficulty doing any manual work, complains of a cough, fatigue, and weight loss, and has been treated for three respiratory infections a year for the past 3 years. On physical examination, CNP notice clubbing of his fingers, use accessory muscles for respiration, wheezing in the lungs, and hyperresonance on percussion of the lungs, and also pulmonary function studies show an FEV1 of 58%. These all symptoms and history represented here most strongly indicate the probability of chronic obstructive pulmonary disease (COPD). COPD is a respiratory disease categorized by chronic airway inflammation, a decrease in lung function over time, and gradual damage in quality of life (Booker, 2014).
History of Present Illness: Mr. Magnuson is a very pleasant 77-year-old gentleman who was previously seen in this office by Elvira Aguila, MD for COPD and hypoxic respiratory failure. He is here today for routine followed up. He was last evaluated in January 2015. Since that time, he states that his dyspnea is worse. He feels that it is related to the weather. He does state that he works around the house, although he does have significant functional limitations because of shortness of breath. His wife also confirms that he is able to do less and less. He has a stable, minimal cough. He is using 4L of oxygen at night as well as, as needed throughout the day. He continues to smoke three to four cigarettes on
D.Z.is a 65-year-old man admitted to medical ward with an exacerbation of chronic obstructive pulmonary disease (COPD; emphysema). Past medical history (PMH) indicates hypertension (HTN), well managed with enalapril (Vasotec) past six years, diagnosis (Dx) of pneumonia yearly for the past three years. D.Z. appears cachectic with difficulty breathing at rest. Patient reports productive cough with thick yellow-green sputum. He seems anxious and irritable during subjective data collection. He states, he has been a 2-pack-a-day smoker for 38 years. He complains of (c/o) insomnia and
COPD is one of the greatest causes of disability and mortality in the twenty first century with future predictions painting an even graver story. Occupation, genome, and primarily smoking are the main causes of COPD. COPD is the third leading cause of death in America, claiming the lives of 134,676 Americans in 2010. Symptoms are typical of a constant smokers cough which progresses into the debilitating palliative stage of the disease; the development of co-morbidities exacerbates these symptoms. COPD has a complex pathophysiology involving hyperinflation, excessive mucus production and airway remodeling; diagnosis is through lung function tests. COPD is poorly managed with few effective treatments and a poor
For this discussion topic, I decided to talk about COPD. COPD stands for chronic obstructive pulmonary disease, which causes obstructed airflow from the lungs. Some symptoms of COPD is coughing, shortness of breath, wheezing, chest tightness, having to clear the throat due to excess mucus in the lungs and lack of energy. Test that could be done to help diagnosis COPD would be a pulmonary function test, chest x-ray, CT scan and arterial blood gas analysis. A pulmonary function test is the most common lung test. During this test, the patient will blow into a large tube connected to a spirometer. This machine measures how much air the lungs can hold and how fast the patient can blow out air. The chest x-ray can show emphysema, which is one of
The World Health Organization (WHO) (2006A) defines COPD as a disease state characterized by airflow limitation that is not wholly reversible. The airflow limitation is usually both progressive and associated with abnormal inflammatory response of the lungs to noxious particles or gases. John's chronic bronchitis is defined, clinically, as the presence of a chronic productive cough for 3 months in each of 2 successive years, provided other causes of chronic cough have been ruled out. (Mannino, 2003). The British lung Foundation (BLF) (2005) announces that chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes which is the explanation for John's dyspnea. The BLF (2005) believe that when the bronchi become inflamed less air is able to flow to and from the lungs and once the bronchial tubes have been irritated over a long period of time, excessive mucus is produced. This increased sputum results from an increase in the size and number of goblet cells (Jeffery, 2001) resulting in John's excessive mucus production. The lining of the bronchial tubes becomes thickened and an irritating cough develops, (Waugh & Grant 2004) which is an additional symptoms that john is experiencing.
COPD is a disease that depletes a person of air. This disease is the fourth top cause of death in the United States. COPD describes several lung diseases including emphysema, chronic bronchitis, refractory asthma, and other forms of bronchiectasis. There is no average case, as every case is different from the next. This disease is long term but treatable.
The article “How Do I Handle a Claim of Sexual Assault by a Close Friend?” by Zwame Anthony Appiah explains several ways to approach someone who has either been sexually assaulted, has sexually assaulted someone, or hides their misery behind their Facebook posts. The article begins by discussing the way to approach the victim of ones friend’s assault, and the author of the article says, “Because you are not close to the victim, you’re not in a good position to help her think about her decisions… But you are in a good position to talk to your friend who, it seems, carried out the assault.” (Appiah 20). The article continues by explaining that one’s friend may not be extremely receptive to one’s advice, but one should still be willing to give
Have you ever known a person who smokes and has a hard time doing every day activities, due to difficulty of breath, or constantly coughing. He or she may have Chronic Obstructive Pulmonary Disease, or COPD. COPD is a progressive and treatable lung disease that causes shortness of breath due to obstruction of air way (COPD, 2013). Progressive means that is gradually gets worse over time. It is a combination of chronic bronchitis and emphysema (Causes,2014). Chronic bronchitis is inflammation of the bronchioles, which causes mucus build up (Davis,2016). Emphysema is when the air sacs get enlarged (Smoking, 2016). Since the disease does not have a cure yet it is important to know pathology (path of disease), epidemiology (who is effected in a population), ethology (who is effected genetically), manifestation (symptoms), treatment, and outcome.
Chronic Obstructive Pulmonary Disease, also known as COPD, is the third leading cause of death in the United States. COPD includes extensive lungs diseases such as emphysema, non-reversible asthma, specific forms of bronchiectasis, and chronic bronchitis. This disease restricts the flow of air in and out of the lungs. Ways in which these limitations may occur include the loss of elasticity in the air sacs and throughout the airways, the destruction of the walls between air sacs, the inflammation or thickening of airway walls, or the overproduction of mucus in airways which can lead to blockage. Throughout this paper I am going to explain the main causes, symptoms, diagnosis, and ways to reduce COPD.
Chronic Obstructive Pulmonary Disease also known as COPD, is one of the third leading cause of death in the United States (National Heart Lung and Blood Institute [NHLBI], 2013a). According to the Centers for Disease Control and Prevention (CDC) (2015) approximately 15 million Americans are affected by COPD, with a morbidity rate of 6.8 million. Data from the CDC from 2011 states that 6.3% of the U.S population suffer from this disease; Florida has the COPD prevalence rate of 7.1% with the highest percentage going to Kentucky with a rate 9.3% as summarized by the COPD foundation (2015). CDC calculated the cost of having COPD as $32.1 billion in 2010 and they expect it to rise to $49 billion by 2020, all for a disease that could be prevented. Additionally CDC has stated the mortality rate has decreased in men in the United States from 57.0 per 100,000 to 47.6 per 100,000 from 1999 to 2010. However, regarding the rate for women, there has not been much change during the same time period. The rate shifted from 35.3 per 100,000 to 36.4 per 100,000 (CDC, 2014).
As an individual grows older, the body will also undergo changes to its system. The effects of changes on the respiratory system can cause problems to develop more easily and be more difficult to manage. Some changes that occur over time are that the nose tissue has reduced support which causes symptoms that interfere with air passage and reduced secretions causing tickling of the throat and coughing. The trachea will stiffen causing more difficulty in the coughing process making the ability to expel lodged items less effectively. The lungs will become smaller; the recoil of the lungs is decrease forcing the body to use other muscles in order to maintain the proper amount of gas exchanges. The thorax and the diaphragm lose skeletal muscle strength causing a reduction in vital capacity and residual volume left in the lungs. Elderly are also more apt to getting respiratory infections because their immune and lymphatic systems also are undergoing changes as they age. All of these changes mentioned above not only impact just the respiratory system but they also force an individual to change their normal daily functions. An
There are no cure for this disease. However, there are different treatment to prevent further deterioration of the lungs function in order to improve the quality of life of the patient by increasing capacity of their physical activity. One of the main severe complication a patient with COPD can develop is exacerbation. Increased breathlessness, increased sputum volume and purulent sputum are the signs and symptoms of exacerbation. Early detection of the signs of exacerbation can help keep the condition of the patient from worsening. The treatments of COPD mainly aims at controlling the symptoms of exacerbation such as taking inhalers. Patients who are over the age of 35 and ex-smokers with chronic cough and bronchitis are recommended to have spirometer (NICE, 2004). This is because it is possible to delay or prevent patients from developing severe case of COPD is identified before they lose their lungs functions. Oxygen therapy is another treatment for COPD as the patients with this condition has high
I will analyse the prevalence of the condition and what the potential causes may be. My interests have been directed to pre hospital care and community lead treatment packages, which are potentially available to the patient, as this is the acute environment, which I will have contact with in my employment as a paramedic. The initial reading was to understand COPD as a chronic condition, what is COPD? and its prevalence in the population. The (World health organisation, 2000), states that one in four deaths in the world are caused by COPD. In 2010 (Vos T Flaxman etal, 2012), says globally there were approximately 329 million, which is 4.8% of the population who are affected by this chronic condition, In the UK (NICE, 2010), have estimated that 3 million people suffer from COPD, with more yet to be diagnosed. This information about the amount of people living with this condition was surprising, as I little knowledge of its existence. During the early 1960’s (Timothy Q. Howes, 2005), says the term COPD had been designated as a single term unifying all the chronic respiratory diseases. Since then the term COPD, has been sub divided in to three umbrella areas, Bronchitis, Emphysema and Chronic asthma, which are separate conditions, which I have been previously aware of as their individual conditions. The 58 year old patient who we visited,
All over the world, chronic obstructive pulmonary disease (COPD) is a very significant and prevalent cause of morbidity and mortality, and it is increasing with time (Hurd, 2000; Pauwels, 2000; Petty, 2000). Due to the factor of COPD being an underdiagnosed and undertreated disease, the epidemiology (Pauwels, Rabe, 2004) is about 60 to 85 % with mild or moderate COPD remaining undiagnosed (Miravitlles et al., 2009; Hvidsten et al., 2010).